Skip to main content

Daclizumab Reduces MS Relapse Rate by 45%, Compared With Interferon β-1a

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Daclizumab Reduces MS Relapse Rate by 45%, Compared With Interferon β-1a

User login

Username

Password

Reset your password

Type	Lead	score